Mebeverine for Pediatric Functional Abdominal Pain : A Randomized, Placebo-Controlled Trial
Mebeverine for Pediatric Functional Abdominal Pain : A Randomized, Placebo-Controlled Trial
About this item
Full title
Author / Creator
Publisher
Cairo, Egypt: Hindawi Puplishing Corporation
Journal title
Language
English
Formats
Publication information
Publisher
Cairo, Egypt: Hindawi Puplishing Corporation
Subjects
More information
Scope and Contents
Contents
We evaluated the effectiveness of an antispasmodic, mebeverine, in the treatment of childhood functional abdominal pain (FAP). Children with FAP (n = 115, aged 6–18 years) received mebeverine (135 mg, twice daily) or placebo for 4 weeks. Response was defined as ≥2 point reduction in the 6-point pain scale or “no pain.” Physician-rated global severi...
Alternative Titles
Full title
Mebeverine for Pediatric Functional Abdominal Pain : A Randomized, Placebo-Controlled Trial
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4095832
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4095832
Other Identifiers
ISSN
2314-6133
E-ISSN
2314-6141
DOI
10.1155/2014/191026
